Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
152
Frequently Asked Questions
What is Market Cap of Entrada Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Entrada Therapeutics Inc market cap is $299.7M.
What is the 52-week high for Entrada Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Entrada Therapeutics Inc 52 week high is $16.45 as of July 06, 2026.
What is the 52-week low for Entrada Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Entrada Therapeutics Inc 52 week low is $4.93 as of July 06, 2026.
What is Entrada Therapeutics Inc stock price today?
Entrada Therapeutics Inc stock price today is $7.71.
What was Entrada Therapeutics Inc stock price yesterday?
Entrada Therapeutics Inc stock price yesterday was $7.72.
What is the PE ratio of Entrada Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Entrada Therapeutics Inc's P/E ratio is -1.93.
What is the Price-to-Book ratio of Entrada Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Entrada Therapeutics Inc P/B ratio is 1.1065.
What is the 50-day moving average of Entrada Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Entrada Therapeutics Inc 50-day moving average is $8.35.
How many employees does Entrada Therapeutics Inc have?